BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 8269141)

  • 1. Thromboembolic events in prosthetic valve recipients: what is the safe level of anticoagulation?
    Acar J
    J Heart Valve Dis; 1993 Jul; 2(4):395-7. PubMed ID: 8269141
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for prevention of thromboembolic events in valvular heart disease. Ad Hoc Committee of the Working Group on Valvular Heart Disease, European Society of Cardiology.
    Gohlke-Bärwolf C; Acar J; Burckhardt D; Oakley C; Butchart E; Krayenbühl P; Hall R; Bodnar E; Krzeminska-Pakula M; Delahaye JP
    J Heart Valve Dis; 1993 Jul; 2(4):398-410. PubMed ID: 8269142
    [No Abstract]   [Full Text] [Related]  

  • 3. German experience with low intensity anticoagulation (GELIA): protocol of a multi-center randomized, prospective study with the St. Jude Medical valve.
    Horstkotte D; Bergemann R; Althaus U; Babin-Ebell J; Chares M; Dahm M; Eigel P; Elert O; Emmrich K; Geiger AW
    J Heart Valve Dis; 1993 Jul; 2(4):411-9. PubMed ID: 8269143
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A retrospective, non-randomized study.
    Albertal J; Sutton M; Pereyra D; Segura EV; Aramburu DF; Lardani H; Diaz R
    J Heart Valve Dis; 1993 May; 2(3):302-7. PubMed ID: 8269123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of thrombosis in heart valve diseases].
    Meyer BJ; Beer JH
    Ther Umsch; 1998 Dec; 55(12):756-61. PubMed ID: 10025189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recommendations for prevention of thromboembolism in heart valve diseases. Working Group on Valvular Heart Disease, European Society of Cardiology].
    Gohlke-Bärwolf C; Acar J; Oakley C; Butchart E; Burckhardt D; Delahaye JP; Horstkotte D; Bodnar E; Hall R; Kremer R
    Z Kardiol; 1995 Dec; 84(12):1018-32. PubMed ID: 8578786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation is necessary in all patients with mechanical prostheses in sinus rhythm.
    Duveau D
    Z Kardiol; 1986; 75 Suppl 2():326-31. PubMed ID: 3727712
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of thromboembolism following heart valve replacement].
    van de Loo J; Stenzinger W
    Verh Dtsch Ges Inn Med; 1989; 95():275-82. PubMed ID: 2690497
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulation after bioprosthetic aortic valve replacement.
    Nowell J; Jahangiri M
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1201-2; author reply 1202. PubMed ID: 20951265
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anticoagulation in surgery, after hemorrhagic complications and in pregnancy].
    Gohlke-Bärwolf C
    Z Kardiol; 1998; 87 Suppl 4():56-62. PubMed ID: 9857468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed-dose versus adjusted-dose warfarin in patients with prosthetic heart valves in a peri-urban impoverished population.
    Buchanan-Leel B; Levetan BN; Lombard CJ; Commerford PJ
    J Heart Valve Dis; 2002 Jul; 11(4):583-92; discussion 593. PubMed ID: 12150309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can early thromboembolic complications after valve replacement be avoided?
    Kure HH; Schüller H; Thulin L; Olin C
    Z Kardiol; 1986; 75 Suppl 2():302-4. PubMed ID: 3727707
    [No Abstract]   [Full Text] [Related]  

  • 13. High complication and failure rates of anticoagulant therapy are unavoidable.
    Nitter-Hauge S; Dale J
    Z Kardiol; 1986; 75 Suppl 2():293-7. PubMed ID: 3727705
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticoagulation is necessary in patients with atrial fibrillation after mitral valve replacement with bioprostheses.
    Rothlin ME
    Z Kardiol; 1986; 75 Suppl 2():317-20. PubMed ID: 3727710
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic.
    Cortelazzo S; Finazzi G; Viero P; Galli M; Remuzzi A; Parenzan L; Barbui T
    Thromb Haemost; 1993 Apr; 69(4):316-20. PubMed ID: 8497842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing mechanical valves with reduced anticoagulation.
    Slaughter MS; Jweied E
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1073-85. PubMed ID: 18035923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
    Goldsmith I; Lip GY; Mukundan S; Rosin MD
    J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology.
    Gohlke-Bärwolf C; Acar J; Oakley C; Butchart E; Burckhart D; Bodnar E; Hall R; Delahaye JP; Horstkotte D; Krémer R
    Eur Heart J; 1995 Oct; 16(10):1320-30. PubMed ID: 8746900
    [No Abstract]   [Full Text] [Related]  

  • 19. eComment: Mechanical valve replacement in the elderly: does anticoagulation have benefit?
    Gunay R
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):581-2. PubMed ID: 19773234
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of thromboembolism in heart valve diseases and following heart valve replacement].
    Stenzinger W; van de Loo J
    Internist (Berl); 1989 Aug; 30(8):520-4. PubMed ID: 2676892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.